Design Therapeutics (DSGN) Cash & Current Investments (2020 - 2026)
Design Therapeutics' Cash & Current Investments came in at $207.4 million for Q2 2026, down 4.1% from $216.28 million a year earlier and down 6.9% from the prior quarter.
Powered by 
Analysis
Design Therapeutics (DSGN) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Design Therapeutics' Cash & Current Investments was $219.85 million, down 10.4% from FY2024.
- Cash & Current Investments has declined in each of the last four years, though with a five-year compound annual growth rate of 43.5% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $245.48 million in FY2024 (-12.9%), $281.8 million in FY2023 (-14.7%), $330.39 million in FY2022 (-14.0%) and $384.06 million in FY2021 (+964.2%).
- The five-year range for quarterly Cash & Current Investments is $205.97 million (Q3 2025) to $393.72 million (Q3 2021).
- Year-over-year, Cash & Current Investments has declined for 18 consecutive quarters, with an average decline of 11.8% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 964.2%), and the weakest in Q3 2025 (a decline of 18.9%).
- Business Quant data shows DSGN's Cash & Current Investments at $222.82 million (Q1 2026), $219.85 million (Q4 2025) and $205.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Design Therapeutics | 772.24 Mn | -83.80 Mn | - | 207.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 207.40 Mn |
| Mar 31, 2026 | 222.82 Mn |
| Dec 31, 2025 | 219.85 Mn |
| Sep 30, 2025 | 205.97 Mn |
| Jun 30, 2025 | 216.28 Mn |
| Mar 31, 2025 | 229.67 Mn |
| Dec 31, 2024 | 245.48 Mn |
| Sep 30, 2024 | 254.07 Mn |
| Jun 30, 2024 | 261.02 Mn |
| Mar 31, 2024 | 270.69 Mn |
| Dec 31, 2023 | 281.80 Mn |
| Sep 30, 2023 | 290.94 Mn |
| Jun 30, 2023 | 303.09 Mn |
| Mar 31, 2023 | 315.39 Mn |
| Dec 31, 2022 | 330.39 Mn |
| Sep 30, 2022 | 344.23 Mn |
| Jun 30, 2022 | 359.38 Mn |
| Mar 31, 2022 | 371.22 Mn |
| Dec 31, 2021 | 384.06 Mn |
| Sep 30, 2021 | 393.72 Mn |
API Access
Design Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();